← Evidence map

ReviewTalanta2021

Commercialized diagnostic technologies to combat SARS-CoV2: Advantages and disadvantages.

Briza Pérez-López et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

26 papers cite it

2021
2022
2023
2024
2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33592692